What is the role of gene therapy in the treatment of hemophilia A?

Updated: Jan 14, 2019
  • Author: Douglass A Drelich, MD; Chief Editor: Srikanth Nagalla, MBBS, MS, FACP  more...
  • Print
Answer

With the cloning of FVIII and advances in molecular technologies, the possibility of a cure for hemophilia with gene therapy was conceived. [57] Possible approaches to gene therapy for hemophilia A include the following [58] :

  • Ex vivo gene therapy, in which cells to be transplanted are genetically modified to secrete factor VIII and then are reimplanted into the recipient

  • In vivo gene therapy, in which a vector (typically a virus altered to include FVIII DNA) is directly injected into the patient

  • Nonautologous gene therapy, in which cells modified to secrete FVIII are packaged in immunoprotected devices and implanted into recipients


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!